Biophyll Competitors and Similar CompaniesClear all

Biophyll's competitors and similar companies include Gilead Sciences, MilliporeSigma, Clinical Trials of Texas and iNtRON Biotechnology.

	Biophyll Biophyll is a company sourcing, manufacturing, and developing biological products of animal, human, and plant origin.	Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.	MilliporeSigma MilliporeSigma (also known as Sigma-Aldrich) is a biotech company that provides laboratory and production materials.	Clinical Trials of Texas Clinical Trials of Texas (CTT, also known as Flourish Research - San Antonio) is a clinical research organization.	iNtRON Biotechnology iNtRON Biotechnology is a research and development company developing bio-drugs and conducting clinical studies.
Founding Date	Founding Date 2007	Founding Date 1987	Founding Date 1975	Founding Date 2001	Founding Date 1999
Type	Type Private	Type Public	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Manufacturing & Industrial biotech clinical research pharma	Tags Manufacturing & Industrial biotech clinical research drug development pharma	Tags Manufacturing & Industrial biotech clinical research life sciences pharma	Tags Healthcare biotech clinical research pharma	Tags Manufacturing & Industrial biotech clinical research pharma
Locations	Locations Dietersburg, DE HQ	Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more	Locations Burlington, US HQ Vienna, AT São Paulo, BR Saint Quentin Fallavier, FR Taufkirchen, DE Bengaluru, IN Rehovot, IL see more	Locations San Antonio, US HQ	Locations Seongnam-si, KR HQ
Employees	Employees 2	Employees 18,0006% increase	Employees 10,502	Employees 642% decrease	Employees 76
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $29.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₩6.4b (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods $6.2b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods ₩1.5b (FY, 2024)
Gross profit	Gross profit N/A	Gross profit $23.2b (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit ₩5b (FY, 2024)
Net income	Net income N/A	Net income $8.5b (FY, 2025)	Net income $703.2m (FY, 2024)	Net income N/A	Net income (₩2.6b) (FY, 2024)